{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T01:45:31Z","timestamp":1768700731501,"version":"3.49.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.phrs.2016.02.025","type":"journal-article","created":{"date-parts":[[2016,3,17]],"date-time":"2016-03-17T20:26:42Z","timestamp":1458246402000},"page":"137-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Cardiotrophin-1 therapy prevents gentamicin-induced nephrotoxicity in rats"],"prefix":"10.1016","volume":"107","author":[{"given":"Yaremi","family":"Quir\u00f3s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Blanco-Gozalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose I.","family":"Sanchez-Gallego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco J.","family":"L\u00f3pez-Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda P.","family":"Perez de Obanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"L\u00f3pez-Novoa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2016.02.025_bib0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ki.2010.337","article-title":"New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view","volume":"79","author":"Lopez-Novoa","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.phrs.2016.02.025_bib0010","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.taap.2007.05.004","article-title":"Glomerular nephrotoxicity of aminoglycosides","volume":"223","author":"Martinez-Salgado","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phrs.2016.02.025_bib0015","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1128\/AAC.43.5.1003","article-title":"Aminoglycosides: nephrotoxicity","volume":"43","author":"Mingeot-Leclercq","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.phrs.2016.02.025_bib0020","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0378-4274(90)90067-V","article-title":"Pathogenic factors in aminoglycoside-induced nephrotoxicity","volume":"51","author":"Kacew","year":"1990","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.phrs.2016.02.025_bib0025","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/0006-2952(90)90078-Y","article-title":"Aminoglycoside-induced renal phospholipidosis and nephrotoxicity","volume":"40","author":"Laurent","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2016.02.025_bib0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1681\/ASN.V4181","article-title":"Can pharmacokinetic dosing decrease nephrotoxicity associated with aminoglycoside therapy","volume":"4","author":"Leehey","year":"1993","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phrs.2016.02.025_bib0035","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1139\/y95-232","article-title":"Protective effect of human ulinastatin against gentamicin-induced acute renal failure in rats","volume":"74","author":"Nakakuki","year":"1996","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.phrs.2016.02.025_bib0040","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1046\/j.1523-1755.2001.059003959.x","article-title":"Expression of osteopontin in gentamicin-induced acute tubular necrosis and its recovery process","volume":"59","author":"Xie","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.phrs.2016.02.025_bib0045","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/toxsci\/kfq267","article-title":"An integrative overview on the mechanisms underlying the renal tubular cytotoxicity of gentamicin","volume":"119","author":"Quiros","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.phrs.2016.02.025_bib0050","first-page":"444","article-title":"Effect of gentamicin on glomerular ultrastructure","volume":"98","author":"Avasthi","year":"1981","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.phrs.2016.02.025_bib0055","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/jac\/6.3.381","article-title":"The mechanism of the decline in glomerular filtration rate in gentamicin-induced acute renal failure in the rat","volume":"6","author":"Baylis","year":"1980","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.phrs.2016.02.025_bib0060","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/ki.1981.19","article-title":"Pathophysiology of altered glomerular function in aminoglycoside-treated rats","volume":"19","author":"Schor","year":"1981","journal-title":"Kidney Int."},{"key":"10.1016\/j.phrs.2016.02.025_bib0065","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/ki.1983.205","article-title":"Reduction of renal blood flow and proximal bicarbonate reabsorption in rats by gentamicin","volume":"24","author":"Klotman","year":"1983","journal-title":"Kidney Int."},{"key":"10.1016\/j.phrs.2016.02.025_bib0070","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00428-004-0977-5","article-title":"Plasma protein extravasation and vascular endothelial growth factor expression with endothelial nitric oxide synthase induction in gentamicin-induced acute renal failure in rats","volume":"444","author":"Goto","year":"2004","journal-title":"Virchows Arch."},{"key":"10.1016\/j.phrs.2016.02.025_bib0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000084657","article-title":"Protective effect of l-arginine intake on the impaired renal vascular responses in the gentamicin-treated rats","volume":"100","author":"Secilmis","year":"2005","journal-title":"Nephron Physiol."},{"key":"10.1016\/j.phrs.2016.02.025_bib0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/08860229409044852","article-title":"Roles of hemodynamic and tubular factors in gentamicin-mediated nephropathy","volume":"16","author":"Hishida","year":"1994","journal-title":"Ren. Fail."},{"issue":"3","key":"10.1016\/j.phrs.2016.02.025_bib0085","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.phrs.2010.04.004","article-title":"Gentamicin-induced nephrotoxicity: do we have a promising therapeutic approach to blunt it ?","volume":"62","author":"Balakumar","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2016.02.025_bib0090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/1359-6101(96)00007-X","article-title":"Cardiotrophin-1: a multifunctional cytokine that signals via LIF receptor-gp 130 dependent pathways","volume":"7","author":"Pennica","year":"1996","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.phrs.2016.02.025_bib0095","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0008-6363(01)00294-2","article-title":"Cardiotrophin-1 can protect cardiac myocytes from injury when added both prior to simulated ischaemia and at reoxygenation","volume":"51","author":"Brar","year":"2001","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2016.02.025_bib0100","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0008-6363(00)00186-3","article-title":"Cardiotrophin-1 protects the human myocardium from ischemic injury. Comparison with the first and second window of protection by ischemic preconditioning","volume":"48","author":"Ghosh","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2016.02.025_bib0105","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/08977190701781289","article-title":"Cardioprotective role of cardiotrophin-1 gene transfer in a murine model of myocardial infarction","volume":"25","author":"Ruixing","year":"2007","journal-title":"Growth Factors"},{"key":"10.1016\/j.phrs.2016.02.025_bib0110","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1073\/pnas.97.1.315","article-title":"Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy","volume":"97","author":"Kunisada","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2016.02.025_bib0115","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1084\/jem.20061421","article-title":"Cardiotrophin-1 defends the liver against ischemia-reperfusion injury and mediates the protective effect of ischemic preconditioning","volume":"203","author":"Iniguez","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.phrs.2016.02.025_bib0120","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1001\/archsurg.141.11.1077","article-title":"Therapeutic potential of cardiotrophin 1 in fulminant hepatic failure: dual roles in antiapoptosis and cell repair","volume":"141","author":"Ho","year":"2006","journal-title":"Arch. Surg."},{"key":"10.1016\/j.phrs.2016.02.025_bib0125","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0016-5085(03)00698-X","article-title":"Protection against liver damage by cardiotrophin-1: a hepatocyte survival factor up-regulated in the regenerating liver in rats","volume":"125","author":"Bustos","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2016.02.025_bib0130","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1478-3231.2008.01687.x","article-title":"Cardiotrophin-1 enhances regeneration of cirrhotic liver remnant after hepatectomy through promotion of angiogenesis and cell proliferation","volume":"28","author":"Yang","year":"2008","journal-title":"Liver Int."},{"key":"10.1016\/j.phrs.2016.02.025_bib0135","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1083\/jcb.148.2.325","article-title":"Cytokine-induced nuclear factor kappa B activation promotes the survival of developing neurons","volume":"148","author":"Middleton","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.phrs.2016.02.025_bib0140","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/jnr.22269","article-title":"Caspase inhibition by cardiotrophin-1 prevents neuronal death in vivo and in vitro","volume":"88","author":"Peng","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.phrs.2016.02.025_bib0145","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1523\/JNEUROSCI.21-04-01283.2001","article-title":"Cardiotrophin-1, a muscle-derived cytokine, is required for the survival of subpopulations of developing motoneurons","volume":"21","author":"Oppenheim","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2016.02.025_bib0150","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1006\/mcne.2001.1058","article-title":"Cytokines promote motoneuron survival through the Janus kinase-dependent activation of the phosphatidylinositol 3-kinase pathway","volume":"18","author":"Dolcet","year":"2001","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.phrs.2016.02.025_bib0155","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/TP.0b013e3182a74db4","article-title":"Cardiotrophin-1 administration protects from ischemia-reperfusion renal injury and inflammation","volume":"96","author":"Garcia-Cenador","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.phrs.2016.02.025_bib0160","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/toxsci\/kft007","article-title":"Cardiotrophin-1 administration prevents the renal toxicity of iodinated contrast media in rats","volume":"132","author":"Quiros","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.phrs.2016.02.025_bib0165","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2174\/092986713804806702","article-title":"Effects and mechanism of organ protection by cardiotrophin-1","volume":"20","author":"Garcia-Cenador","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.phrs.2016.02.025_bib0170","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/ki.2010.439","article-title":"Urinary levels of regenerating islet-derived protein III beta and gelsolin differentiate gentamicin from cisplatin-induced acute kidney injury in rats","volume":"79","author":"Ferreira","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.phrs.2016.02.025_bib0175","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/ki.2010.267","article-title":"Sub-nephrotoxic doses of gentamicin predispose animals to developing acute kidney injury and to excrete ganglioside M2 activator protein","volume":"78","author":"Quiros","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.phrs.2016.02.025_bib0180","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/ki.2010.11","article-title":"Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway","volume":"77","author":"Morales","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.phrs.2016.02.025_bib0185","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nm1426","article-title":"Vav3 proto-oncogene deficiency leads to sympathetic hyperactivity and cardiovascular dysfunction","volume":"12","author":"Sauzeau","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2016.02.025_bib0190","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/ndt\/gfs380","article-title":"Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature","volume":"28","author":"Vanmassenhove","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.phrs.2016.02.025_bib0195","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/1382-6689(96)00034-8","article-title":"Increased severity of gentamicin nephrotoxicity in aging rats is mediated by a reduced glomerular nitric oxide production","volume":"2","author":"Valdivielso","year":"1996","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.phrs.2016.02.025_bib0200","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1382-6689(97)00148-8","article-title":"Effect of nitric oxide synthesis modification on renal function in gentamicin-induced nephrotoxicity","volume":"3","author":"Valdivielso","year":"1997","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.phrs.2016.02.025_bib0205","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.niox.2010.12.001","article-title":"Nitric oxide (NO) is associated with gentamicin (GENTA) nephrotoxicity and the renal function recovery after suspension of GENTA treatment in rats","volume":"24","author":"Christo","year":"2011","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.phrs.2016.02.025_bib0210","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1006\/cyto.1996.0123","article-title":"In vivo effects of cardiotrophin-1","volume":"8","author":"Jin","year":"1996","journal-title":"Cytokine"},{"key":"10.1016\/j.phrs.2016.02.025_bib0215","doi-asserted-by":"crossref","first-page":"H388","DOI":"10.1152\/ajpheart.2000.279.1.H388","article-title":"Effects of cardiotrophin-1 on hemodynamics and endocrine function of the heart","volume":"279","author":"Hamanaka","year":"2000","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2016.02.025_bib0220","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0003-4975(03)00339-4","article-title":"Cardiotrophin-1 is a prophylactic against the development of chronic hypoxic pulmonary hypertension in rats","volume":"76","author":"Nomura","year":"2003","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.phrs.2016.02.025_bib0225","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/ndt\/gfi225","article-title":"Kallikrein\/kinin protects against gentamicin-induced nephrotoxicity by inhibition of inflammation and apoptosis","volume":"21","author":"Bledsoe","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.phrs.2016.02.025_bib0230","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cyto.2006.10.015","article-title":"Cardiotrophin-1 induces interleukin-6 synthesis in human umbilical vein endothelial cells","volume":"36","author":"Fritzenwanger","year":"2006","journal-title":"Cytokine"},{"key":"10.1016\/j.phrs.2016.02.025_bib0235","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cyto.2007.05.015","article-title":"Cardiotrophin-1 induces interleukin-6 synthesis in human monocytes","volume":"38","author":"Fritzenwanger","year":"2007","journal-title":"Cytokine"},{"key":"10.1016\/j.phrs.2016.02.025_bib0240","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","article-title":"The pro- and anti-inflammatory properties of the cytokine interleukin-6","volume":"1813","author":"Scheller","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2016.02.025_bib0245","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI1368","article-title":"IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses","volume":"101","author":"Xing","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2016.02.025_bib0250","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1089\/jir.2014.0225","article-title":"STAT3-Activating cytokines: a therapeutic opportunity for inflammatory bowel disease ?","volume":"35","author":"Nguyen","year":"2015","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.phrs.2016.02.025_bib0255","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1182\/blood.V75.1.40.40","article-title":"Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: iL-6 suppresses IL-1 and TNF","volume":"75","author":"Schindler","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2016.02.025_bib0260","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1096\/fj.02-0670fje","article-title":"Exercise and IL-6 infusion inhibit endotoxin-induced TNF-\u03b1 production in humans","volume":"17","author":"Starkie","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2016.02.025_bib0265","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1128\/MCB.10.5.2327","article-title":"Activation of interleukin-6 gene expression through the NF-\u03baB transcription factor","volume":"10","author":"Libermann","year":"1990","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.phrs.2016.02.025_bib0270","doi-asserted-by":"crossref","first-page":"10193","DOI":"10.1073\/pnas.90.21.10193","article-title":"Transcription factors NF-IL6 and NF-\u03baB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8","volume":"90","author":"Matsusaka","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2016.02.025_bib0275","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/j.1460-2075.1990.tb08316.x","article-title":"A nuclear factor for IL-6 expression (NF-IL6) is a member of a C\/EBP family","volume":"9","author":"Akira","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/j.phrs.2016.02.025_bib0280","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/0923-2494(92)80011-9","article-title":"Regulation of IL6 gene expression","volume":"143","author":"Sehgal","year":"1992","journal-title":"Res. Immunol."},{"key":"10.1016\/j.phrs.2016.02.025_bib0285","doi-asserted-by":"crossref","first-page":"27920","DOI":"10.1074\/jbc.270.46.27920","article-title":"Triggering of the human interleukin-6 gene by interferon-\u03b3 and tumor necrosis factor-\u03b1 in monocytic cells involves cooperation between interferon regulatory factor-1, NF\u03baB, and Sp1 transcription factors","volume":"270","author":"Sanc\u00e9au","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2016.02.025_bib0290","doi-asserted-by":"crossref","first-page":"25900","DOI":"10.1074\/jbc.M707692200","article-title":"Interleukin (IL) 1\u03b2 Induction of IL-6 Is Mediated by a Novel Phosphatidylinositol 3-Kinase-dependent AKT\/I\u03baB Kinase \u03b1 Pathway Targeting Activator Protein-1","volume":"283","author":"Cahill","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2016.02.025_bib0295","first-page":"472","article-title":"The effect of gentamicin on antidiuretic hormone-stimulated osmotic water flow in the toad urinary bladder","volume":"101","author":"Humes","year":"1983","journal-title":"J. Lab. Clin. Med."},{"issue":"54","key":"10.1016\/j.phrs.2016.02.025_bib0300","first-page":"273","article-title":"Studies on the mechanism of non-oliguric experimental acute renal failure","volume":"1981","author":"Appel","year":"1981","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.phrs.2016.02.025_bib0305","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1161\/HYPERTENSIONAHA.112.194407","article-title":"Cardiotrophin 1 is involved in cardiac, vascular, and renal fibrosis and dysfunction","volume":"60","author":"Lopez-Andres","year":"2012","journal-title":"Hypertension"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816301566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816301566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T02:31:01Z","timestamp":1718418661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816301566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":61,"alternative-id":["S1043661816301566"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.02.025","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiotrophin-1 therapy prevents gentamicin-induced nephrotoxicity in rats","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}